Real-World Effectiveness of Primary Series and Booster Doses of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2 Variant Infection in China: A Retrospective Cohort Study.

Authors:
Tang L; Wang FZ; Rodewald LE; Wang XY; Liu SY and 25 more

Journal:
J Infect Dis

Publication Year: 2023

DOI:
10.1093/infdis/jiad090

PMCID:
PMC10420401

PMID:
37005365

Journal Information

Full Title: J Infect Dis

Abbreviation: J Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Potential conflicts of interest. The authors: No reported conflicts of interest.: All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed."

Evidence found in paper:

"Financial support. This work was supported by the Emergency Key Program of Guangzhou Laboratory, project Evaluation of Effectiveness of COVID-19 Vaccine against SARS-CoV-2 Outbreak in China (SRPG22–009). Funding to pay the Open Access publication charges for this article was provided by the Emergency Key Program of Guangzhou Laboratory. Financial support."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025